Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yali Yang

Showing results (361-370 of 365) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 365 results.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic MelanomaMohamed A Gouda, Bettzy Stephen, Yanyan Tian, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
First-Phase Ejection Fraction, a Measure of Preclinical Heart Failure, Is Strongly Associated With Increased Mortality in Patients With COVID-19Haotian Gu, Chiara Cirillo, Adam A Nabeebaccus, et al.
Cell Reports. Medicine|May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancersAung Naing, Xiqi Li, Qi Wang, et al.
Pageof 37

Showing results (361-370 of 365) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 365 results.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic MelanomaMohamed A Gouda, Bettzy Stephen, Yanyan Tian, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
First-Phase Ejection Fraction, a Measure of Preclinical Heart Failure, Is Strongly Associated With Increased Mortality in Patients With COVID-19Haotian Gu, Chiara Cirillo, Adam A Nabeebaccus, et al.
Cell Reports. Medicine|May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancersAung Naing, Xiqi Li, Qi Wang, et al.
Pageof 37